Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001839882-24-039514
Filing Date
2024-11-15
Accepted
2024-11-15 16:20:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO THE SCHEDULE 13D gsk-sc13da_111224.htm SC 13D/A 50020
  Complete submission text file 0001839882-24-039514.txt   52048
Mailing Address 79 NEW OXFORD STREET LONDON X0 WC1A 1DG
Business Address 79 NEW OXFORD STREET LONDON X0 WC1A 1DG 011442080475000
GSK plc (Filed by) CIK: 0001131399 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 223 N. MATHILDA AVE. SUNNYVALE CA 94086
Business Address 223 N. MATHILDA AVE. SUNNYVALE CA 94086 (650) 938-6300
23andMe Holding Co. (Subject) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-91734 | Film No.: 241468167
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)